Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

Manu Nair

Loading...
Default Featured Image
News
02.14.20

Oblato Biotech Company Acquires Hearing Loss Drug Discovered by Hough Ear Institute Scientists

Read more
Default Featured Image
News, OKBio
06.05.19

Delegation Sharing Oklahoma’s Good News Bioscience Story at BIO International Convention

Read more
Default Featured Image
News
10.30.18

Out of the valley: Mayo Clinic shares development philosophy with OK Innovation Model

Read more
Default Featured Image
News
08.08.18

Manu’s Minute: Structured Capital in Oklahoma

Read more
Default Featured Image
Entrepreneur, News, Publish in TEN, SeedStep Angels
06.20.14

Q&A with Manu Nair

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E